Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 4,667 Shares of Company Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 4,667 shares of the stock in a transaction on Friday, October 9th. The shares were sold at an average price of $130.77, for a total transaction of $610,303.59. Following the transaction, the chief executive officer directly owned 469,158 shares in the company, valued at approximately $61,351,791.66. This represents a 0.98% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 0.8%

Adtalem Global Education stock traded down $1.02 during mid-day trading on Friday, hitting $129.27. The company’s stock had a trading volume of 195,878 shares, compared to its average volume of 365,483. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market cap of $4.38 billion, a price-to-earnings ratio of 18.36, a price-to-earnings-growth ratio of 0.94 and a beta of 0.65. The business has a 50 day moving average price of $128.36 and a 200-day moving average price of $123.69. Adtalem Global Education Inc. has a 12 month low of $86.97 and a 12 month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, analysts forecast that Adtalem Global Education Inc. will post 9 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CVSA shares. Truist Financial cut Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price target on the stock. in a research note on Thursday, September 3rd. BMO Capital Markets cut their target price on shares of Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating on the stock in a report on Monday. Weiss Ratings downgraded shares of Adtalem Global Education from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday. Finally, Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Sunday, September 27th. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $151.67.

Institutional Investors Weigh In On Adtalem Global Education

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management acquired a new position in Adtalem Global Education Inc. (NYSE:CVSA) during the second quarter, according to its most recent filing with the SEC. The firm acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors and hedge funds own 98.84% of the company’s stock.

Adtalem Global Education Company Profile

Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.

The company’s academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.